[Treatment of non-Hodgkin's lymphoma associated with acquired immnodeficiency syndrome (AIDS) at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán].
BACKGROUND
Survival in patients with acquired immunodeficiency syndrome (AIDS) related non-Hodgkin's Lymphoma has improved with the use of High Active Antiretroviral Therapy (HAART) and less toxic chemotherapy.


METHODS
Clinical characteristics and outcome among patients treated for AIDS related non-Hodgkin's Lymphoma are described. Nine patients were studied retrospectively. Overall survival (OS) and Free Disease Survival (FDS) using a Kaplan-Meier model were analyzed.


RESULTS
Patients received (DA-EPOCH) etoposide, prednisone, vincristine, doxorubicin and cyclophosphamide. The overall Survival was 18 months and 13 month Free Disease Survival with a median follow-up of 16 months showing full response in 8/9 patients was observed.


CONCLUSIONS
A very satisfactory treatment response in this group of patients expressed as an increased Overall Survival was noted.
Uriarte-Duque
Juan
J
Departamento de Hematología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, SSA, Mexico DF, México. juanuriarte3@hotmail.com
Hernández-Riverab
Gabriela
G
D000328:Adult; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D016483:Lymphoma, AIDS-Related / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies